These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 16263156

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Apicidin, a novel histone deacetylase inhibitor, has profound anti-growth activity in human endometrial and ovarian cancer cells.
    Ueda T, Takai N, Nishida M, Nasu K, Narahara H.
    Int J Mol Med; 2007 Feb; 19(2):301-8. PubMed ID: 17203205
    [Abstract] [Full Text] [Related]

  • 5. Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Gynecol Oncol; 2008 Apr; 109(1):107-14. PubMed ID: 18234298
    [Abstract] [Full Text] [Related]

  • 6. Anticancer activity of MS-275, a novel histone deacetylase inhibitor, against human endometrial cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Anticancer Res; 2006 Apr; 26(2A):939-45. PubMed ID: 16619490
    [Abstract] [Full Text] [Related]

  • 7. Human endometrial and ovarian cancer cells: histone deacetylase inhibitors exhibit antiproliferative activity, potently induce cell cycle arrest, and stimulate apoptosis.
    Takai N, Narahara H.
    Curr Med Chem; 2007 Apr; 14(24):2548-53. PubMed ID: 17979707
    [Abstract] [Full Text] [Related]

  • 8. Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells.
    Takai N, Ueda T, Nasu K, Narahara H.
    Gynecol Oncol; 2008 Nov; 111(2):336-43. PubMed ID: 18790523
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells.
    Takai N, Desmond JC, Kumagai T, Gui D, Said JW, Whittaker S, Miyakawa I, Koeffler HP.
    Clin Cancer Res; 2004 Feb 01; 10(3):1141-9. PubMed ID: 14871994
    [Abstract] [Full Text] [Related]

  • 11. Histone deacetylase inhibitors induce growth inhibition, cell cycle arrest and apoptosis in human choriocarcinoma cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Int J Mol Med; 2008 Jan 01; 21(1):109-15. PubMed ID: 18097623
    [Abstract] [Full Text] [Related]

  • 12. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells.
    Ahn MY, Jung JH, Na YJ, Kim HS.
    Gynecol Oncol; 2008 Jan 01; 108(1):27-33. PubMed ID: 17920664
    [Abstract] [Full Text] [Related]

  • 13. K252a is highly effective in suppressing the growth of human endometrial cancer cells, but has little effect on normal human endometrial epithelial cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Oncol Rep; 2008 Mar 01; 19(3):749-53. PubMed ID: 18288411
    [Abstract] [Full Text] [Related]

  • 14. Human ovarian carcinoma cells: histone deacetylase inhibitors exhibit antiproliferative activity and potently induce apoptosis.
    Takai N, Kawamata N, Gui D, Said JW, Miyakawa I, Koeffler HP.
    Cancer; 2004 Dec 15; 101(12):2760-70. PubMed ID: 15536623
    [Abstract] [Full Text] [Related]

  • 15. Cucurbitacin D induces growth inhibition, cell cycle arrest, and apoptosis in human endometrial and ovarian cancer cells.
    Ishii T, Kira N, Yoshida T, Narahara H.
    Tumour Biol; 2013 Feb 15; 34(1):285-91. PubMed ID: 23150173
    [Abstract] [Full Text] [Related]

  • 16. PK11195 enhances chemosensitivity to cisplatin and paclitaxel in human endometrial and ovarian cancer cells.
    Takai N, Ueda T, Nishida M, Nasu K, Narahara H.
    Int J Mol Med; 2010 Jan 15; 25(1):97-103. PubMed ID: 19956907
    [Abstract] [Full Text] [Related]

  • 17. Histone deacetylase inhibitor, Romidepsin (FK228) inhibits endometrial cancer cell growth through augmentation of p53-p21 pathway.
    Li LH, Zhang PR, Cai PY, Li ZC.
    Biomed Pharmacother; 2016 Aug 15; 82():161-6. PubMed ID: 27470351
    [Abstract] [Full Text] [Related]

  • 18. HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferation.
    Yeung A, Bhargava RK, Ahn R, Bahna S, Kang NH, Lacoul A, Niles LP.
    Biomed Pharmacother; 2012 Apr 15; 66(3):232-6. PubMed ID: 22436652
    [Abstract] [Full Text] [Related]

  • 19. Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation.
    Bao L, Diao H, Dong N, Su X, Wang B, Mo Q, Yu H, Wang X, Chen C.
    Cell Biol Toxicol; 2016 Dec 15; 32(6):469-482. PubMed ID: 27423454
    [Abstract] [Full Text] [Related]

  • 20. The anti-tumor effects and molecular mechanisms of suberoylanilide hydroxamic acid (SAHA) on the aggressive phenotypes of ovarian carcinoma cells.
    Chen S, Zhao Y, Gou WF, Zhao S, Takano Y, Zheng HC.
    PLoS One; 2013 Dec 15; 8(11):e79781. PubMed ID: 24236158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.